Immunological evaluation of vector-expressed M2 and HA genes of H5N1 influenza virus in mice

Shengwu Gongcheng Xuebao/Chinese Journal of Biotechnology

Volumn 26, Issue 5, 2010, Pages 649-656

  Guo, Jianqiang ^a   Yao, Lihong ^a   Chen, Aijun ^a   Xu, Yi ^a   Liu, Xiaoyu ^a   Yuelong, Shu ^b   Zhang, Zhiqing ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b Institute for Viral Disease Control and Prevention   (China)

Author keywords

Combined immunization; H5N1 influenza virus; Hemagglutinin (HA); Matrix protein 2 (M2)

Indexed keywords

DNA VACCINE; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; M2 PROTEIN, INFLUENZA A VIRUS; MATRIX PROTEIN; RECOMBINANT PROTEIN;

ADENOVIRUS; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; FEMALE; GENE VECTOR; GENETICS; IMMUNOLOGY; INFLUENZA VIRUS A H5N1; METABOLISM; MOUSE; VACCINATION;

ADENOVIRIDAE; ANIMALS; FEMALE; GENETIC VECTORS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; MICE; MICE, INBRED BALB C; RECOMBINANT PROTEINS; VACCINATION; VACCINES, DNA; VIRAL MATRIX PROTEINS;

ADENOVIRIDAE; AVIAN INFLUENZA VIRUS; BACTERIA (MICROORGANISMS); MUS; ORTHOMYXOVIRIDAE;

EID: 77954805288     PISSN: 10003061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Yu H, Shu Y, Hu S, et al. The first confirmed human case of avian influenza A(H5N1) in mainland China. Lancet, 2006, 367(9504): 84.
2. Holterman L, Vogels R, van der Vlugt R, et al. Novel replication-incompetent vector derived from adenovirus type 11(Ad11) for vaccination and gene therapy: low seroprevalence and non-cross-reactivity with Ad5. J Virol, 2004, 78(23): 13207-13215.
3. Gao W, Soloff AC, Lu X, et al. Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization. J Virol, 2006, 80(4): 1959-1964.
4. Hoeslscher MA, Garg S, Bangari DS, et al. Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice. Lancet, 2006, 367(9509): 475-481.
5. Fedson DS. Pandemic influenza and the global vaccine supply. Clin Infect Dis, 2003, 36(12): 1552-1561.
6. Kochanek S, Schiedner G, Volpers C. High-capacity 'gutless' adenoviral vectors. Curr Opin Mol Ther, 2001, 3(5): 454-463.
7. Singh N, Pandey A, Jayashankar L, et al. Bovine adenoviral vector-based H5N1 influenza vaccine overcomes exceptionally high levels of pre-existing immunity against human adenovirus. Mol Ther, 2008, 16(5): 965-971.
8. Ito T, Gorman OT, Kawaoka Y, et al. Evolutionary analysis of the influenza A virus M gene with comparison of the M1 and M2 proteins. J Virol, 1991, 65(10): 5491-5498.
9. Black RA, Rota PA, Gorodkova N, et al. Antibody response to the M2 protein of influenza A virus expressed in insect cells. J Gen Virol, 1993, 4(Pt1): 143-146.
10. Treanor JJ, Tierney EL, Zebedee SL, et al. Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice. J Virol, 1990, 64(3): 1375-1377.